Skip to content
10-Q

Quarterly Report

Eucrates Biomedical Acquisition Corp.

0001410578-22-002601

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 15, 2022 13.46M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$194.39K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$168.03K
Cash And Equivalents Q2 2022 · Jun 30, 2022 $104.77K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $49.16K
Cash And Equivalents Q2 2022 · Jun 30, 2021 $383.23K
Cash And Equivalents Q2 2022 · Dec 31, 2020 $551.26K
Stockholders Equity Q2 2022 · Jun 30, 2022 −$3.79M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$4.16M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$5.49M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 −$6.69M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$7.32M
Stockholders Equity restated Q2 2022 · Dec 31, 2020 −$9.31M
Current Liabilities Q2 2022 · Jun 30, 2022 $201.89K
Current Liabilities Q2 2022 · Dec 31, 2021 $38.46K
Total Liabilities Q2 2022 · Jun 30, 2022 $4.11M
Total Liabilities Q2 2022 · Dec 31, 2021 $5.8M
Current Assets Q2 2022 · Jun 30, 2022 $222.17K
Current Assets Q2 2022 · Dec 31, 2021 $264.16K
Total Assets Q2 2022 · Jun 30, 2022 $105.18M
Total Assets Q2 2022 · Dec 31, 2021 $105.11M
Net Income Q2 2022 · Jun 30, 2022 $431.66K
Net Income Q2 2022 · Jun 30, 2022 $1.76M
Net Income Q2 2022 · Mar 31, 2022 $1.32M
Net Income Q2 2022 · Jun 30, 2021 $630.59K
Net Income Q2 2022 · Jun 30, 2021 $2.62M
Net Income Q2 2022 · Mar 31, 2021 $1.99M
Operating Income Q2 2022 · Jun 30, 2022 −$137.48K
Operating Income Q2 2022 · Jun 30, 2022 −$268.51K
Operating Income Q2 2022 · Jun 30, 2021 −$124.43K
Operating Income Q2 2022 · Jun 30, 2021 −$249.77K